Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?

Luise Goldmann, Rundan Duan, Thorsten Kragh, Georg Wittmann, Christian Weber, Reinhard Lorenz, Philipp von Hundelshausen, Michael Spannagl, Wolfgang Siess*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4021-4033
Number of pages13
JournalBlood advances
Volume3
Issue number23
DOIs
Publication statusPublished - 10 Dec 2019

Keywords

  • MULTIPLE ELECTRODE AGGREGOMETRY
  • IBRUTINIB
  • PHOSPHORYLATION
  • POLYMORPHISM
  • AGGREGATION
  • THROMBOSIS
  • ACID
  • GPVI
  • TOOL
  • BTK

Cite this

Goldmann, L., Duan, R., Kragh, T., Wittmann, G., Weber, C., Lorenz, R., von Hundelshausen, P., Spannagl, M., & Siess, W. (2019). Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT? Blood advances, 3(23), 4021-4033. https://doi.org/10.1182/bloodadvances.2019000617